Proteomics News and Research

RSS

The term 'proteome' was first coined in 1994, and refers to all the proteins in a cell, tissue, or organism. Proteomics refers to the study of the proteome. Because proteins are involved in almost all biological activities, the proteome is a rich source of biological information.

Study identifies four different autism subtypes based on brain activity and behavior

People with autism spectrum disorder can be classified into four distinct subtypes based on their brain activity and behavior, according to a study from Weill Cornell Medicine investigators.

7 Apr 2023

Specific proteins in the blood may help predict which COVID-19 patients may become critically ill

Researchers at Washington University School of Medicine in St. Louis have identified specific proteins that may help predict which COVID-19 patients may need to be placed on ventilators to breathe and which are most likely to die of the virus.

6 Apr 2023

New model for proteomic cardiovascular risk assessment among chronic kidney disease patients

Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease's prevalence - 10 percent of individuals across the globe suffer from CKD - there are limited tools for measuring cardiac risk for CKD patients, until now.

4 Apr 2023

Lipid Nanoparticles (LNPs) and DNA delivery – unlocking the future of medical research

In this interview, Kate Stumpo speaks to Michael Girgis about Lipid nano particles, and the future of the field.

From Bruker Daltonics 31 Mar 2023

Biological BMI measures metabolic health more accurately

Researchers analyze longitudinal and cross-sectional changes in blood analytes associated with variations in body mass index.

23 Mar 2023

Study outlines a meta-scale approach to quantifying the human proteome

A major puzzle of biology is that while the human genome contains roughly 20,000 genes, many comparatively primitive organisms - including the universally-studied worm C. elegans - have almost the same number of genes.

23 Mar 2023

Machine learning applications for the diagnosis, treatment and prognosis of cancer

Researchers review the application of machine learning in improving cancer diagnosis, treatment, and prognosis.

19 Mar 2023

Structure of cellular shredders varies according to cell type, study shows

"Miniature shredders" are at work in each cell, disassembling and recycling cell components that are defective or no longer required.

16 Mar 2023

Research uncovers a possible explanation for sex differences in pancreatic cancer

Immunotherapy is an effective form of therapy for different types of cancer. However, for pancreatic cancer, its effect is limited and differs between men and women.

15 Mar 2023

EVOSEP and ReSyn Biosciences partner to integrate their technologies into new clinical proteomics solutions

The ability to process large and clinically relevant cohorts in a robust and high-throughput manner is important to unlocking the full potential of proteomics for precision medicine.

From Evosep 14 Mar 2023

Hyperinflammation triggers long COVID headaches

Researchers characterize the immunological and metabolic alterations involved in chronic headache onset during post-acute sequelae of COVID-19.

13 Mar 2023

Study identifies a potential new treatment approach for acute myeloid leukemia

A team of researchers has discovered a potential therapeutic that can synergize with existing drugs to more effectively kill certain leukemia cells.

8 Mar 2023

Study: Over 20% of patients at high risk of cardiovascular disease refuse to take statin medications

Heart disease is the leading cause of death worldwide, killing someone in the United States every 34 seconds, according to the Centers for Disease Control and Prevention.

28 Feb 2023

Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors

Tecan is pleased to announce the launch of the Resolvex A200 Omics and Resolvex A200 24, the next generation of Resolvex A200 positive pressure processors.

From Tecan 27 Feb 2023

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

A small but significant metabolic difference between human and mouse lung tumor cells, has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results, and pointing toward new strategies for developing cancer treatments.

24 Feb 2023

Proteomics News and Research

Further Reading

Study identifies four different autism subtypes based on brain activity and behavior

Specific proteins in the blood may help predict which COVID-19 patients may become critically ill

New model for proteomic cardiovascular risk assessment among chronic kidney disease patients

Lipid Nanoparticles (LNPs) and DNA delivery – unlocking the future of medical research

Biological BMI measures metabolic health more accurately

Study outlines a meta-scale approach to quantifying the human proteome

Machine learning applications for the diagnosis, treatment and prognosis of cancer

Structure of cellular shredders varies according to cell type, study shows

Research uncovers a possible explanation for sex differences in pancreatic cancer

EVOSEP and ReSyn Biosciences partner to integrate their technologies into new clinical proteomics solutions

Hyperinflammation triggers long COVID headaches

Study identifies a potential new treatment approach for acute myeloid leukemia

Study: Over 20% of patients at high risk of cardiovascular disease refuse to take statin medications

Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

Study finds protein biomarkers in women with perinatal mood and anxiety disorder symptoms

When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

Researchers reveal the metabolic reactions upon activating Akt2 enzyme

In-depth assessment of muscle biopsies in patients with long COVID

Protein degradation approach can be used to hit an ‘undruggable’ target against cancer

Industry Focus eBook - Protein Analysis (3rd edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo